Bourne R B, Laskin Richard S, Guerin J S
London Health Sciences Center, University of Western Ontario, Ontario, Canada.
Orthopedics. 2007 Aug;30(8 Suppl):83-5.
The first 100 consecutive Genesis II (Smith & Nephew; Memphis, Tenn) total knee replacements (TKR) procedures performed in 97 patients by the senior investigators (RBB, RSL) had a Kaplan-Meier survivorship of 96% +/- 2% at 12 years with any reoperation as the endpoint. Significant improvements in health-related quality-of-life outcome measures were noted. There were no revisions for implant-related factors (ie, polyethylene wear, osteolysis, or aseptic loosening). No implant demonstrated radiographic loosening. The features of this device are discussed as well as its long-term performance.
资深研究者（RBB、RSL）对97例患者进行的连续100例Genesis II（史赛克公司；田纳西州孟菲斯）全膝关节置换（TKR）手术，以任何再次手术为终点，12年时的Kaplan-Meier生存率为96%±2%。健康相关生活质量结局指标有显著改善。未因植入物相关因素（即聚乙烯磨损、骨溶解或无菌性松动）进行翻修。没有植入物显示影像学松动。本文讨论了该装置的特点及其长期性能。
